Navigation Links
Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
Date:4/23/2010

tin Investment Advisors.
  • William M. Daley, vice chairman and head of the office of corporate responsibility and chairman of the Midwest, JPMorgan Chase & Co.
  • W. James Farrell, retired chairman and chief executive officer, Illinois Tool Works Inc.
  • H. Laurance Fuller, retired co-chairman of the board, BP Amoco, p.l.c.
  • William A. Osborn, retired chairman and chief executive officer, Northern Trust Corporation and The Northern Trust Company.
  • The Rt. Hon. Lord Owen CH FRCP, chairman of Europe Steel, Ltd.
  • Roy S. Roberts, managing director, Reliant Equity Investors.
  • Samuel C. Scott III, retired chairman, president and chief executive officer, Corn Products International, Inc.
  • William D. Smithburg, retired chairman, president and chief executive officer, The Quaker Oats Company.
  • Glenn F. Tilton, chairman, president and chief executive officer, UAL Corporation and United Air Lines, Inc., a wholly owned subsidiary of UAL Corporation.
  • Miles D. White, chairman of the board and chief executive officer, Abbott.

  • W. Ann Reynolds retired from the board of directors after 30 years of service.

    About Abbott

    Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs approximately 83,000 people and markets its products in more than 130 countries.

    Abbott's news releases and other info
    '/>"/>

    SOURCE Abbott
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
    2. Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
    3. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
    4. Abbotts ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study
    5. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
    6. Abbott Announces Positive One-Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
    7. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
    8. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
    9. Abbotts XIENCE(TM) V Drug Eluting Stent Demonstrates Consistent and Positive Clinical Outcomes Out to Two Years
    10. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
    11. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/27/2015)... 2015  Later this week, Cardinal Health Specialty ... economic outcomes research (HEOR) studies that reinforce the ... value-based reimbursement strategies.   Dr. ... officer of Cardinal Health Specialty Solutions, says that ... for more than a decade that clinical trials ...
    (Date:5/27/2015)... YORK , May 27, 2015  Relmada Therapeutics, ... for the treatment of chronic pain, announced today that ... Conference on Monday, June 1, 2015 at the Luxe ... . The presentation by Michael ... corporate development, is scheduled to begin at 2:00 p.m. ...
    (Date:5/27/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... findings from its recent three-day Key Opinion Leader ... Company,s percutaneous hepatic perfusion (PHP) therapy for the treatment ... Paris and included more ...
    Breaking Medicine Technology:New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 2New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies 3Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 3Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients 2Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients 3Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients 4Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients 5
    (Date:5/27/2015)... Florida (PRWEB) May 27, 2015 ... impartial customer satisfaction surveys in the multiple services ... poll to determine the highest ranked Electronic Health ... part of a special research focus on implemented ... announced those software vendors with the highest scores ...
    (Date:5/27/2015)... AR (PRWEB) May 27, 2015 ... today announce a partnership to provide CMSA's Career ... community. This collaboration seeks to strengthen the case/care ... through CMSA’s CKP program. The mutually beneficial agreement ... identifying individual skills of talent in the healthcare, ...
    (Date:5/27/2015)... Difass USA, a modern supplement brand committed ... first three flagship products, Dormiva™, Relaxiva™ and Reminiva™. All ... http://www.difassusa.com . , A restful night’s sleep is ... people struggle with getting the full amount of sleep ... designed to help you fall asleep and stay asleep, ...
    (Date:5/27/2015)... IL (PRWEB) May 27, 2015 On ... North-based advertising agency, will partner with LifeSource to host ... event will take place in a LifeSource donor coach ... a.m. to 4:00 p.m. , Demand for whole blood ... in Illinois, during the summer months. LifeSource requires approximately ...
    (Date:5/27/2015)... 27, 2015 Genius Monkey is pleased ... programmatic marketing technology, they have boosted sales for the ... a regional level for seven Utah-based dealers. , ... television and radio media. In 2014 the Utah Honda ... of Genius Monkey , shifted their marketing campaigns ...
    Breaking Medicine News(10 mins):Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 2Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 3Health News:Cloud-Based Electronic Health Record firms sweep top physician satisfaction rankings for Small and Solo Practices, reveals 2015 Black Book survey 4Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:Supplement Brand Difass USA Launches in the U.S. with Three Flagship Products Designed to Bring Balance Back to Your Life 2Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Genius Monkey Boosts Utah Honda Dealers Website Traffic 142% 2
    ... intramuscular injection, study says , , THURSDAY, Feb. 7 ... for delivering DNA vaccines than intramuscular injection, a new ... Genetic Vaccines and Therapy , researchers at the ... protein from the human papillomavirus (HPV), which causes cervical ...
    ... With Mass ... Production Starting in May, 2008, HERZLIYA, Israel, February ... the availability of a,stand-alone chip that integrates Dblur,s groundbreaking Software ... Lens(TM),camera modules of up to 3.2Mp. Samples are currently available ...
    ... Presidential Campaign ... Issue, WEST PALM BEACH, ... and small, in promoting the fact,that they hire and employ only legally documented ... online and,offline, the fact that they exclusively employ legal workers., Companies will ...
    ... MDTH ), a healthcare provider focused on ... of cardiovascular,disease, today announced its operating results for ... First Quarter 2008 Results, During its ... of Harlingen Medical Center ("HMC"). As part of ...
    ... - DRAXIS Health Inc. (TSX:,DAX); (Nasdaq: DRAX ... and,the year ended December 31, 2007. Results for ... quarter of 2006 were impacted by lower product ... business,segments, compounded by the significantly stronger Canadian dollar ...
    ... Nuvelo, Inc.,(Nasdaq: NUVO ) today announced that it ... CEO & Investor Conference February 13, 2008 ... Chairman and CEO, http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=NUVO&item_id=1752425 , Fourth Quarter ... Call & Webcast February 27, 2008 4:30 p.m. ...
    Cached Medicine News:Health News:Tattooing Best Way to Deliver DNA Vaccines 2Health News:Dblur Announces the Availability of a Software Lens(TM) Enabled Chip 2Health News:Dblur Announces the Availability of a Software Lens(TM) Enabled Chip 3Health News:Legal Employer Provides Companies with Competitive Edge by Assuring Consumers that Workers are Legally Documented 2Health News:MedCath Corporation Reports First Quarter Earnings 2Health News:MedCath Corporation Reports First Quarter Earnings 3Health News:MedCath Corporation Reports First Quarter Earnings 4Health News:MedCath Corporation Reports First Quarter Earnings 5Health News:MedCath Corporation Reports First Quarter Earnings 6Health News:MedCath Corporation Reports First Quarter Earnings 7Health News:MedCath Corporation Reports First Quarter Earnings 8Health News:MedCath Corporation Reports First Quarter Earnings 9Health News:MedCath Corporation Reports First Quarter Earnings 10Health News:MedCath Corporation Reports First Quarter Earnings 11Health News:MedCath Corporation Reports First Quarter Earnings 12Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 2Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 3Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 4Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 5Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 6Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 7Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 8Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 9Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 10Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 11Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 12Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 13Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 14Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 15Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 16Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 17Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 18Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 19Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 20Health News:DRAXIS Health Reports Fourth Quarter and Year End Results 21
    Inquire...
    Inquire...
    Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies....
    Premier pouches provide the ultimate in skin protection with our long wearing Flextend skin barriers and superior comfort with our soft and silky ComfortWear panels....
    Medicine Products: